FLPP logo purple 1


RISK-HUNT3R: Risk assessment of chemicals integrating human centric next generation testing strategies promoting the 3Rs (2021-2026)

ALISE: Antibody Light-Induced Selectivity Enhancement (2021-2025)

BBCE: Baltic Biomaterials Centre of Excellence (2020-2026)

• ERA4TB: European Regimen Accelerator for Tuberculosis (2020-2025)

• SPRINGBOARD: Springboard for excellence in advanced development of antibacterials (2020-2023)

• InterTAU: Integrative Structural Biology of Pathological tau Protein, an Appealing Therapeutic Target for Alzheimer´s Disease Modifying Drugs (2020-2023)

• FAT4BRAIN: Networking for excellence in functional pharmacology to study the role of fatty acid metabolism in neurological disorders (2019-2022)

• IT-DED³: European Training Network for Integrated Training in Dry Eye Disease Drug Development (2018-2021)

• CARTNET: Combatting Antimicrobial Resistance Training Network (2018-2021)


ESIF projects

BioDrug: Biotechnology at Latvian Institute of Organic Synthesis to Achieve Excellence in Drug Discovery (2019-2023)


ENABLE: European Gram Negative AntiBacterial Engine (2014-2021)

ERA-NET Projects

• TENTACLES: Temperature-responsive Nanogels for Targeted Delivery of MicroRNAs in Wound Healing and Tissue Regeneration Applications (2020-2023)

• NANO4GLIO: Nanomedicine for Glioblastoma Therapy (2020-2022)

RESET-ME: Restoring E. coli Sensitivity for Antibiotics by Blocking TolC-Mediated Efflux (2019-2022)

EXPLORE: Exploration of the TPP Riboswitch as a New Target for Antibiotics (2019-2022)

INNOCENT: Innovative Nanopharmaceuticals: Targeting Breast Cancer Stem Cells by a Novel Combination of Epigenetic and Anticancer Drugs with Gene Therapy (2017-2021)


ERNEST: European Research Network on Signal Transduction (2019-2023)

European Cholangiocarcinoma Network (2019-2023)

New diagnostic and therapeutic tools multidrug resistant tumors (2018-2022)

INNOGLY: Innovation with Glycans: new frontiers from synthesis to new biological targets (2019-2023)

• GLYCONanoPROBES: Functional Glyconanomaterials for the Development of Diagnostics and Targeted Therapeutic Probes (2019-2023)

Nano2Clinic: Cancer nanomedicine – from the bench to the bedside (2018-2022)

NutRedOx: Personalized Nutrition in aging society: redox control of major age-related diseases (2017-2021)

EU-CARDIOPROTECTION: Realising the therapeutic potential of novel cardioprotective therapies (2017-2021)

BIONECA: Biomaterials and Advanced Physical Techniques for Regenerative Cardiology and Neurology (2017-2021)

BESTPRAC: The voice of research administrators – building a network of administrative excellence

CHAOS: C-H Activation in Organic Synthesis (2016-2020)

MITOEAGLE: Mitochondrial mapping: Evolution – Age – Gender – Lifestyle – Environment (2016-2020)

SYNSTAR: Synergistic Stimulation of Adrenergic Receptors for the Treatment of Obesity (2020-2023)